Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 2/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.32 |
| ▸ | GCG | P01275 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
| ▸ | AURKA | O14965 | 1/20 | 0.30 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.30 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.30 |
| ▸ | TPX2 | Q9ULW0 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29567598 | 1.00 | JAK2 (0.33) | JAK2GRM4GCGEGLN1AURKA | |
| SCHEMBL22735745 | 0.89 | GRM4 (0.34) | JAK2GRM4GCGEGLN1AURKA | |
| SCHEMBL29567619 | 0.89 | GRM4 (0.34) | JAK2GRM4GCGEGLN1AURKA | |
| SCHEMBL22716928 | 0.88 | GRM4 (0.33) | JAK2GRM4GCGMAPK1 | |
| SCHEMBL29567676 | 0.88 | GRM4 (0.33) | JAK2GRM4GCGMAPK1 | |
| SCHEMBL22736480 | 0.87 | JAK2 (0.34) | JAK2GRM4GCGEGLN1 | |
| SCHEMBL29567482 | 0.87 | JAK2 (0.34) | JAK2GRM4GCGEGLN1 | |
| SCHEMBL22736497 | 0.87 | JAK2 (0.34) | JAK2GRM4GCGEGLN1 | |
| SCHEMBL22736494 | 0.87 | JAK2 (0.34) | JAK2GRM4GCGEGLN1 | |
| SCHEMBL29480601 | 0.87 | JAK2 (0.34) | JAK2GRM4GCGEGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020240586-A1 | NOVEL COMPOUNDS FOR INHIBITION OF JANUS KINASE 1 | MANKIND PHARMA LTD. (IN) | 2020-12-03 | — | — | WO | disclosed |